About TLA

A company built on 15 years of research

Jonas Winqvist
Chief Executive Officer

Jonas Winqvist

Experience in strategy consulting and finance. Partner at Implement Consulting Group. Previously, Vice President at CapGemini, and Auditor at E&Y.

jonas.winqvist@tlatherapies.com

Ola Winqvist
Chief Scientific Officer, Chairman of the Board

Ola Winqvist

Ola is a Senior Consultant in Clinical Immunology at Karolinska University Hospital and co-founder of several biotech companies based on his inventions. Previously, Ola was a Professor of Cellular Immunotherapy and Head of Translational Immunology at the Karolinska Institutet. 

Ludvig Linton
Chief Technical Officer

Ludvig Linton

Ludvig holds a PhD from Karolinska Institute where his research focus was immunological mechanisms in inflammatory bowel disease. Ludvig has more than 10 years of experience within translational immunology and science commercialization.

Sara Lavasani
Director of Clinical Operations

Sara Lavasani

Sara holds a Master of Science from Linköpings University and has 10+ years of experience within clinical research both from pharmaceutical companies and clinical research organizations.

Augusta Broomé
QA/RA Manager

Augusta Broomé

Augusta holds a Master of Science from Uppsala University. During her career Augusta has focused on specializing in immunology and the QA/RA field.

Catharina Johansson
Project Leader

Catharina Johansson

Catharina holds a PhD in Immunology from the Karolinska Institutet. Catharina has more than 30 years experience of immunological research at Karolinska Institutet, Uppsala University and AstraZeneca.

Ahsan Amjad
Board member

Ahsan Amjad

Ahsan is a health-tech entrepreneur and investor. In addition to his role at TLA, Ahsan is co-founder and Chairman at Accelerated Innovation, Managing Director at Immune Therapy Holdings, and has been an investor and Board member at several digital health companies such as KRY, HerCare and ABC Labs.

Hans Glise
Board member

Hans Glise

Hans Glise MD, PhD has a professorship in surgery, vast experience of clinical research both from the clinical side and as Head of Clinical research in several Therapy Areas inAstra Zeneca, Novo Nordisk and UCB. Dr Glise also was the driving force behind the creation of SCUR, a clinical research group of 30 clinics in medicine and Surgery in Sweden, Norway and Finland.

Stefan Warin
Board Member

Stefan Warin

Extensive experience of managing biotechnology and pharmaceutical companies. Previously, President, CEO, and Chairman of the Board in Companies including Farmos Group, Ferring and Nordic Group.